Log in

DIABETES

Stem-cell derived pancreatic endoderm cells in the treatment of T1DM

  • Research Highlight
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

References

Original articles

Related article

  • Nair, G. G., Tzanakakis, E. S. & Hebrok, M. Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy. Nat. Rev. Endocrinol. 16, 506–518 (2020)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claire Greenhill.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greenhill, C. Stem-cell derived pancreatic endoderm cells in the treatment of T1DM. Nat Rev Endocrinol 18, 67 (2022). https://doi.org/10.1038/s41574-021-00620-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-021-00620-z

  • Springer Nature Limited

Navigation